Prediction of Oncotype DX using DRFs
Résumé
Oncotype DX (ODX) is a multi-gene expression signature for breast cancer that provides prognostic and predictive breast cancer recurrence information for estrogen receptor (ER)-positive and HER2 negative patients. This test can predict if a chemotherapy treatment would be beneficial. However, this test is expensive and several studies have shown its link with certain clinico-pathological data. The result of the test is a score between 0 and 100 and guides clinicians regarding prescription of chemotherapy (e.g. for score higher than 25). Aim: Predict the ODX score based on histopathological variables. Proposed methodology: Probabilistic forecast using Distributional Regression Forest (DRF; [1])
Origine : Fichiers produits par l'(les) auteur(s)